Lessons learned from the blockade of immune checkpoints in cancer immunotherapy.
Li X, Shao C, Shi Y, Han W. · 2018
Read Lessons learned from the blockade of immune checkpoints in cancer immunotherapy. by Li X, Shao C, Shi Y, Han W. (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6389077.txt.
Description
Li and co-authors review lessons from checkpoint blockade in the Journal of Hematology and Oncology. These drugs free immune cells to attack cancer. Only a share of patients gain lasting benefit, though, and most tumors resist.
Cancer can escape immune watch through many routes, the review explains. That variety makes single-drug cures unlikely for most patients. The authors sort the known resistance paths and match each with paired treatments. Some pairs join checkpoint drugs with standard chemo or radiation. Their aim is to help trials pick patients and drug pairs with more care.
Catalog record
| CREATOR | Li X, Shao C, Shi Y, Han W. |
|---|---|
| YEAR | 2018 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 159 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |